Followers | 28 |
Posts | 1889 |
Boards Moderated | 0 |
Alias Born | 04/04/2017 |
Thursday, March 16, 2023 3:17:45 AM
The bigger problem is most investors still can't accept the fact that 99% of OTC pinks collapsed Anywhere from 70 to 99% ... And even OTCQB is down over 50%. Nothing mysterious about a pull out of this magnitude.
There's only a handful of companies that will make it out of the OTC pinks Given its current stigma..... And if history and experience has any bearing on the future, The only ones that will survive are those that are already turning profits with reasonable revenue. Could some of those revenues be overstated or down right lies?..... I would guess that maybe 70% of OTC Turn out to be exactly that.
Most of OTC Pinks are not audited.. And sometimes there are extenuating circumstances why that may be delayed. But the fact is when you have other legitimate Sources of financial accounting such as Dun and Bradstreet that have Multiple Historical records that backup the vast majority of any companies positive Financials.... Well I think most would consider that a better bet than the majority of companies that dilute a 100, 300, 500% just to stay afloat and show minimal revenue increase.
We will see if you can actually stay away from charging your other "windmill".... I doubt it.... If true..... I might agree to stay at my side of the street..
BTW, Given that anybody left investing in the OTC This far after the collapse... It should be apparent to everybody that any interest here is only for investors with Absolutely no illusion as to this being anything but there gambling portion of the Is there portfolio. Why anybody would be so adamant about trying to dissuade any specific stock Is especially in the OTC pinks..... It really makes no sense to me. Support and advocate for the stock of your choice..... But let others Take their Calculated chances was there preferred choice. The days of trying to steal money away from one stock to pump another 1 are well past
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM